Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents
US7495026B2 · kind B2 · utility
2Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2005 |
| Grant date | Feb 24, 2009 |
| Priority date | — |
| Expiry date | Aug 5, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of Formulas I-II are described,along with methods of using such compounds for the treatment of cancer and pharmeutical formulations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.